White matter alterations in glaucoma and monocular blindness differ outside the visual system.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 03 2021
25 03 2021
Historique:
received:
11
11
2020
accepted:
15
02
2021
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
21
10
2021
Statut:
epublish
Résumé
The degree to which glaucoma has effects in the brain beyond the eye and the visual pathways is unclear. To clarify this, we investigated white matter microstructure (WMM) in 37 tracts of patients with glaucoma, monocular blindness, and controls. We used brainlife.io for reproducibility. White matter tracts were subdivided into seven categories ranging from those primarily involved in vision (the visual white matter) to those primarily involved in cognition and motor control. In the vision tracts, WMM was decreased as measured by fractional anisotropy in both glaucoma and monocular blind subjects compared to controls, suggesting neurodegeneration due to reduced sensory inputs. A test-retest approach was used to validate these results. The pattern of results was different in monocular blind subjects, where WMM properties increased outside the visual white matter as compared to controls. This pattern of results suggests that whereas in the monocular blind loss of visual input might promote white matter reorganization outside of the early visual system, such reorganization might be reduced or absent in glaucoma. The results provide indirect evidence that in glaucoma unknown factors might limit the reorganization as seen in other patient groups following visual loss.
Identifiants
pubmed: 33767217
doi: 10.1038/s41598-021-85602-x
pii: 10.1038/s41598-021-85602-x
pmc: PMC7994383
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
6866Références
Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3803-3812
pubmed: 31504081
Eye (Lond). 2020 Sep;34(9):1546-1553
pubmed: 32152519
Neuroradiology. 2013 Mar;55(4):493-8
pubmed: 23358877
Curr Eye Res. 2012 Sep;37(9):794-802
pubmed: 22631870
NMR Biomed. 2002 Nov-Dec;15(7-8):431-4
pubmed: 12489093
Invest Ophthalmol Vis Sci. 2013 Aug 09;54(8):5353-8
pubmed: 23860758
Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):545-54
pubmed: 23258150
Curr Neuropharmacol. 2018;16(7):971-977
pubmed: 29210654
J Neuroradiol. 2013 May;40(2):89-93
pubmed: 22796270
Neurotherapeutics. 2007 Jul;4(3):316-29
pubmed: 17599699
Neuroradiology. 2013 Feb;55(2):233-43
pubmed: 23223846
PLoS One. 2014 Aug 27;9(8):e105931
pubmed: 25162716
Fluids Barriers CNS. 2015 Jun 29;12:16
pubmed: 26118970
Brain. 2003 Sep;126(Pt 9):2093-107
pubmed: 12821517
Eye (Lond). 2021 Apr;35(4):1281
pubmed: 32518395
Clin Exp Ophthalmol. 2013 Jan-Feb;41(1):43-9
pubmed: 22712443
Eur J Neurosci. 2011 Dec;34(12):1887-94
pubmed: 22082031
Sci Transl Med. 2020 Mar 25;12(536):
pubmed: 32213628
Ophthalmic Physiol Opt. 2016 May;36(3):344-53
pubmed: 27112227
Magn Reson Med. 1999 Sep;42(3):515-25
pubmed: 10467296
Invest Ophthalmol Vis Sci. 2011 Apr 25;52(5):2758-66
pubmed: 21398286
J Neuroophthalmol. 2015 Sep;35 Suppl 1:S22-8
pubmed: 26274833
Front Syst Neurosci. 2015 Apr 28;9:60
pubmed: 25972788
Eye (Lond). 2020 Jan;34(1):178-191
pubmed: 31776450
Neuroimage Clin. 2020;28:102419
pubmed: 33032067
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1201-11
pubmed: 17325164
PLoS One. 2014 May 14;9(5):e97445
pubmed: 24828063
Front Cell Neurosci. 2017 Feb 27;11:53
pubmed: 28289378
Br J Ophthalmol. 2017 Jun;101(6):130-195
pubmed: 28559477
J Vis. 2017 Feb 1;17(2):4
pubmed: 28196374
J Neurol Sci. 2006 Jul 15;246(1-2):79-83
pubmed: 16564058
Trends Neurosci. 1992 Jan;15(1):20-5
pubmed: 1374953
Sci Rep. 2019 Oct 2;9(1):14168
pubmed: 31578409
Radiology. 2009 Aug;252(2):496-501
pubmed: 19435941
Brain Struct Funct. 2019 Nov;224(8):2631-2660
pubmed: 31342157
Clin Exp Ophthalmol. 2017 Jul;45(5):539-547
pubmed: 28129671
Neuroimage. 2018 Dec;183:314-326
pubmed: 30121337
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Neuroimage. 2012 Sep;62(3):1924-38
pubmed: 22705374
J Magn Reson. 2011 Dec;213(2):560-70
pubmed: 22152371
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Cereb Cortex. 2017 Jun 1;27(6):3346-3359
pubmed: 28369290
J Ophthalmic Vis Res. 2016 Apr-Jun;11(2):209-20
pubmed: 27413504
Ophthalmology. 1995 Nov;102(11):1632-8
pubmed: 9098255
Neuroimage. 2018 Dec;183:532-543
pubmed: 30077743
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
World J Radiol. 2014 Dec 28;6(12):895-906
pubmed: 25550994
Magn Reson Med. 2000 Oct;44(4):625-32
pubmed: 11025519
PLoS One. 2012;7(11):e49790
pubmed: 23166771
Prog Brain Res. 2015;221:xxiii-xxiv
pubmed: 26518088
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5876-5884
pubmed: 30543343
Front Neuroanat. 2012 Aug 22;6:32
pubmed: 22936899
Sci Data. 2019 May 23;6(1):69
pubmed: 31123325
PLoS Comput Biol. 2014 Mar 27;10(3):e1003538
pubmed: 24676149
Jpn J Ophthalmol. 2013 May;57(3):257-62
pubmed: 23417328
Brain. 2009 Jul;132(Pt 7):1898-906
pubmed: 19467992
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1313-1322
pubmed: 29625454
Sci Rep. 2016 Jan 08;6:18969
pubmed: 26743811
Semin Ophthalmol. 2013 Jul;28(4):224-9
pubmed: 23662834
AJNR Am J Neuroradiol. 2012 Jan;33(1):128-34
pubmed: 22116110
PLoS One. 2013 Sep 03;8(9):e73208
pubmed: 24019910
Brain Struct Funct. 2016 Dec;221(9):4705-4721
pubmed: 26754839
Nat Commun. 2014 Sep 17;5:4932
pubmed: 25230200
Transl Psychiatry. 2020 Mar 20;10(1):100
pubmed: 32198361
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094
Acta Ophthalmol. 2016 Mar;94(2):113-21
pubmed: 26361248